Britain's Pirbright Institute is partnering with Belgian biotechnology company ViroVet to develop the first antiviral drugs that act against African Swine Fever (ASF), according to a joint statement issued on Wednesday.
from Reuters: Health https://reut.rs/2Kcjm3J
No comments